Search

everythinglearnresearchcommunity

for

Search:↓

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Leonuri Herba alkaloids may help treat hormone-induced enlarged prostate in rats.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Topical finasteride reduces hair loss and promotes hair growth in men and women.

Certain Chinese herbs, especially Cacumen platycladi, can promote hair regrowth and reduce hair loss-related hormone levels in mice.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Finasteride does not prevent bladder cancer.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Lowering certain hormone levels improves treatment for hair loss in young men.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Stem cell therapy could be a promising alternative for hair regrowth with fewer side effects.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Healthy scalp is crucial for hair growth and preventing hair loss.

A vaccine may prevent benign prostatic hyperplasia (BPH).

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Dutasteride reduces DHT more effectively than finasteride.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

Microneedle therapy combined with serum effectively increases hair count in people with hair loss, with no side effects.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Certain finger length ratios and body hair patterns may predict side effects from birth control pills in women.